https://doi.org/10.1038/s41467-023-44211-0
S
S. Wimalasena
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
390
Citations
8
h-index
8
i10-index
S. Wimalasena is an academic researcher from Emory University. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Selenium in Biological Systems & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 8, co-authored 32 publications.
ORCID: 0000-0002-8248-4074Papers by this author
worksIgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
2024 · Nature Communications · 23 citations
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
2025 · Nature Communications · 5 citations
https://doi.org/10.1038/s41467-025-55823-z
Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines
2024 · The Journal of Infectious Diseases · 2 citations
https://doi.org/10.1093/infdis/jiae505
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
2026 · Communications Medicine · 1 citations
https://doi.org/10.1038/s43856-025-01230-w
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
2026 · Communications Medicine · 0 citations
https://doi.org/10.1038/s43856-026-01425-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat